APA

Riedinger J. M., Eche N., Basuyau J. P., Daver A., Touzery C., Mayer F., Coudert B., Fargeot P., Chauffert B., de Gislain C. & Zanetta S. (20020703). [Interpretation of the CA125 kinetics during first line chemotherapy of the ovarian cancer: methodological aspects and characteristic profiles]. : Annales de biologie clinique.

Chicago

Riedinger J M, Eche N, Basuyau J P, Daver A, Touzery C, Mayer F, Coudert B, Fargeot P, Chauffert B, de Gislain C and Zanetta S. 20020703. [Interpretation of the CA125 kinetics during first line chemotherapy of the ovarian cancer: methodological aspects and characteristic profiles]. : Annales de biologie clinique.

Harvard

Riedinger J. M., Eche N., Basuyau J. P., Daver A., Touzery C., Mayer F., Coudert B., Fargeot P., Chauffert B., de Gislain C. and Zanetta S. (20020703). [Interpretation of the CA125 kinetics during first line chemotherapy of the ovarian cancer: methodological aspects and characteristic profiles]. : Annales de biologie clinique.

MLA

Riedinger J M, Eche N, Basuyau J P, Daver A, Touzery C, Mayer F, Coudert B, Fargeot P, Chauffert B, de Gislain C and Zanetta S. [Interpretation of the CA125 kinetics during first line chemotherapy of the ovarian cancer: methodological aspects and characteristic profiles]. : Annales de biologie clinique. 20020703.